| MERCK & CO. INC. |
| USA |
| Gesundheit |
| US58933Y1055 / A0YD8Q |
| 6MK (Frankfurt) / MRK (NYSE) |
| FRA:6MK, ETR:6MK, 6MK:GR, NYSE:MRK |
| https://www.merck.com/ |
|
Merck & Co., Inc. operates as a leading healthcare company worldwide, specializing in the research, development, and commercialization of innovative pharmaceutical products and vaccines. Its portfolio features prominent human health pharmaceuticals s..
>Volltext.. |
| 274750.21 Mio. EUR |
| 312186.88 Mio. EUR |
| 56674.31 Mio. EUR |
| 20866.03 Mio. EUR |
| 7730.24 Mio. EUR |
| 3.08 EUR |
| 42494.27 Mio. EUR |
| 4670.16 Mio. EUR |
| 15477.79 Mio. EUR |
| 0.21 |
| -3.83% |
| -52.01% |
| 2.89 EUR |
| 2.61% |
| 2.66% |
| 15.06.26 - 0.73338€ 16.03.26 - 0.73703504€ >weitere anzeigen... |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 9.670.755 Euro. |
| MERCK & CO, MERCK&CO, MERCK CO, MERCKCO, MRK |
| 09.08.26 |
|
||||
|
||||
|